UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 861177
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,365,249,602
+$4,816,893 QoQ
Shares Held
3,057,396
+1.9% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54.514560756931715.ToString("F0")%
Shared 0.ToString("F0")%
None 45.485439243068285.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. VRTX ranks #1 (31.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,365,249,602 | 3,057,396 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,360,432,709 | 3,000,778 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,130,710,495 | 2,887,117 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,365,638,974 | 3,067,473 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,240,885,145 | 2,559,476 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $937,976,485 | 2,329,219 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,135,477,930 | 2,441,468 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,211,325,744 | 2,584,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,022,474,188 | 2,446,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,057,874,931 | 2,599,904 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $964,560,858 | 2,773,799 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $989,476,249 | 2,811,731 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $885,892,080 | 2,811,731 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $845,956,744 | 2,929,416 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $914,567,674 | 3,158,692 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $879,836,855 | 3,122,314 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $819,272,772 | 3,139,337 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $771,725,121 | 3,514,231 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $500,428,338 | 2,758,853 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $494,325,173 | 2,451,645 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $444,718,932 | 2,069,519 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $493,281,043 | 2,087,167 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $439,213,377 | 1,614,043 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $451,010,805 | 1,553,549 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $333,921,417 | 1,403,326 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||